Iterum Therapeutics (ITRM)
(Delayed Data from NSDQ)
$1.43 USD
-0.03 (-2.05%)
Updated Apr 18, 2024 03:59 PM ET
After-Market: $1.43 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2024
Time: -- |
3/2024 | $-0.57 | 0.00% |
Earnings Summary
For their last quarter, Iterum Therapeutics (ITRM) reported earnings of -$0.94 per share, beating the Zacks Consensus Estimate of $-1.02 per share. This reflects a positive earnings surprise of 7.84%. Look out for ITRM's next earnings release expected on May 10, 2024. For the next earning release, we expect the company to report earnings of -$0.57 per share, reflecting a year-over-year increase of 26.92%.
Earnings History
Price & Consensus
Zacks News for ITRM
Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%
ITRM: What are Zacks experts saying now?
Zacks Private Portfolio Services